Asthma Control Study

NCT03304067 — Not applicable, Completed, 262 participants, Evidation Health

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Digital Health Tool for Parental Management of Childhood Asthma -- Impact on Asthma Control Test Scores

RegistryNCT03304067
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, health services research
Enrollment262 (Actual)
SponsorEvidation Health (Industry); collaborators: Tueo Health
ConditionsChildhood Asthma
InterventionsTueo Program (Behavioral)
Datesstart 2017-10-03, primary completion 2018-05-03, completion 2018-05-03, first posted 2017-10-06, last updated 2018-07-17
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Childhood Asthma All trials of Tueo Program

-Summary

The "Digital Health Tool for Parental Management of Childhood Asthma -- Impact on Asthma Control Test Scores" Study is a 16 week, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Tueo Health program on asthma control as indicated by change in baseline and study end (week 16) score on the Childhood Asthma Control Test score (ages 6- under 12 years) and the Asthma Control Test (ages 12-17 years) in children with uncontrolled asthma as the primary study objective.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
InterventionExperimentalBehavioral: Tueo Program
ControlNo intervention
  • Tueo Program (Behavioral): The asthma management solution utilizes devices (2 to attach on the child's bed and 1 for data transmission), which collect various metrics for a tailored smartphone application experience. The smartphone application provides access to view metrics from the devices, educational and clinical context content, and an asthma coach.

+Outcome measures

Primary outcomes

  • Change in ACT/C-ACT scores [Baseline and Week 16]: Change in ACT/C-ACT scores from baseline to study end

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Parent has a child who is > 6 and < 17.5 years old
* Parent reports child has a diagnosis of asthma
* Child takes daily asthma controller medication
* Child has used rescue inhaler (e.g.albuterol, ProAir, etc) or nebulizer at least 2 times per week in the past 4 weeks
* Child sleeps on a toddler, single, or double bed by themselves
* Child will live in the same home for the majority of the next 16 weeks
* Parent is > 18 years old

Exclusion Criteria:

* Child's asthma has been controlled over the past 4 weeks
* Child has any of the following conditions: sleep apnea, congenital heart disease, cardiac arrhythmias, or any other heart abnormalities, neurologic conditions including seizures, cerebral palsy, muscular dystrophy, genetic conditions or developmental disorders, autism, other major medical condition
* Child is currently pregnant
* Child was born premature (earlier than 36 weeks)
* Parent is not fluent in English
* No in-home WiFi
* Parent does not use an Android phone as their primary phone
* In a household with an existing enrolled participant in the study, even for a different child (e.g. only one child in a household may have questions reported back to the researchers by their parent)
* Lives in Hawaii or Alaska

+Locations (1)

FacilityCityCountryStatus
Evidation HealthSan Mateo, CaliforniaUnited States